N/A
Manufactured by Haleon US Holdings LLC
5,044 FDA adverse event reports analyzed
Last updated: 2026-04-15
METHYLCELLULOSE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Haleon US Holdings LLC. The most commonly reported adverse reactions for METHYLCELLULOSE include NAUSEA, DIARRHOEA, FATIGUE, DRUG INEFFECTIVE, CONSTIPATION. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for METHYLCELLULOSE.
Out of 2,241 classified reports for METHYLCELLULOSE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 5,044 FDA FAERS reports that mention METHYLCELLULOSE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include NAUSEA, DIARRHOEA, FATIGUE, DRUG INEFFECTIVE, CONSTIPATION, DYSPNOEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Haleon US Holdings LLC in connection with METHYLCELLULOSE. Always verify the specific product and NDC with your pharmacist.
Explore other medications manufactured by Haleon US Holdings LLC and compare their safety profiles:
The following drugs share commonly reported adverse reactions with METHYLCELLULOSE: